Finance

Lists
NUTX:NASDAQ
Nutex Health Inc
$212.63
0.00%
(0.00) 1D
Oct 29, 1:48:26 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NUTX...
Open
$212.95
High
$215.97
Low
$211.35
Mkt. cap
1.46B
Avg. vol.
148.11K
Volume
42.86K
P/E ratio
8.39
52-wk high
$226.00
52-wk low
$83.99
EPS
$25.33
Beta
0.54
Shares outstanding
6.85M
No. of employees
1K
Open
$212.95
High
$215.97
Low
$211.35
Mkt. cap
1.46B
Avg. vol.
148.11K
Volume
42.86K
P/E ratio
8.39
52-wk high
$226.00
52-wk low
$83.99
EPS
$25.33
Beta
0.54
Shares outstanding
6.85M
No. of employees
1K
News stories
From web sources and news partners
Profile
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas. Wikipedia
About Nutex Health Inc
CEO-
Employees1.04K
Founded2000
HeadquartersHouston, Texas, United States
SectorHealth care provider
Websitenutexhealth.com
Analyst ratings
Based on 5 analysts giving stock ratings to NUTX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for NUTX in the last 3 months.
Highest
Current $212.63
$336.00 (+58.02%)
Average
$295.40 (+38.93%)
Lowest
$200.00 (-5.94%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Initiated
$336.00
+58%
10/26/2026
Eugene Mannheimer
Freedom Capital Markets
Buy
Maintained
$306.00
+43.9%
09/25/2026
Yuan Zhi
B. Riley Securities
Buy
Maintained
$325.00
+52.8%
09/04/2026
Ben Haynor
Lake Street
Buy
Reiterated
$310.00
+45.8%
08/13/2026
Anthony Vendetti
Maxim Group
Buy
Reiterated
$200.00
-5.9%
08/10/2026
Anderson Schock
B. Riley Securities
Buy
Initiated
$290.00
+36.4%
06/26/2026
Bill Sutherland
Benchmark Co.
Buy
Reiterated
$300.00
+41.1%
03/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
267.80M
151.68M
216.48M
210.75M
Cost of goods sold
107.92M
93.85M
119.26M
64.16M
Cost of revenue
107.92M
93.85M
119.26M
64.16M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.30M
24.32M
14.38M
16.68M
Operating expense
29.52M
-90.09M
15.96M
24.88M
Total operating expenses
137.44M
3.76M
135.22M
89.03M
Operating income
130.37M
147.92M
81.26M
121.72M
Other non operating income
-976.00K
-48.00K
-23.00K
38.00K
EBT including unusual items
123.94M
25.89M
76.56M
117.08M
EBT excluding unusual items
123.94M
142.89M
76.56M
117.08M
Income tax expense
27.14M
9.29M
13.80M
20.77M
Effective tax rate
21.90%
35.86%
18.02%
17.74%
Other operating expenses
-
-
-
-
Net income
55.44M
11.83M
46.81M
65.84M
Net profit margin
20.70%
7.80%
21.62%
31.24%
Earnings per share
7.76
-
5.74
-
Interest and investment income
-
-
-
-
Interest expense
-5.45M
-4.98M
-4.68M
-4.67M
Net interest expenses
-5.45M
-4.98M
-4.68M
-4.67M
Depreciation and amortization charges
5.00M
5.19M
5.49M
5.32M
EBITDA
135.37M
153.10M
86.76M
127.04M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps